Topiramate
Product Images NDC 70934-420

4 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70934-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

022dc727 C077 4611 8a3d 967ee99f9828 01

022dc727 C077 4611 8a3d 967ee99f9828 01
Chemical structure of Topiramate, showing its molecular arrangement with multiple oxygen atoms, methyl groups, and a sulfamate functional group.*
FDA Label Image

022dc727 C077 4611 8a3d 967ee99f9828 02

022dc727 C077 4611 8a3d 967ee99f9828 02
A cumulative rate chart showing time to first seizure for Topiramate at 50 mg/day and 400 mg/day doses. The X-axis represents time in days, up to 500 days, and the Y-axis shows cumulative rate to first seizure. Two lines compare seizure rates over time for the two dose groups with a statistical p-value of 0.0002 indicated.*
FDA Label Image

022dc727 C077 4611 8a3d 967ee99f9828 03

022dc727 C077 4611 8a3d 967ee99f9828 03
A bar chart showing changes from baseline to double-blind phase in average weekly migraine episodes per patient for placebo and Topamax (topiramate) at doses of 50 mg/day, 100 mg/day, and 200 mg/day. Data are presented separately for two studies, Study 10 and Study 11, with statistical significance indicated for higher doses of Topamax compared to placebo.*
FDA Label Image

70934 420 30 Master Bottle Label Approval Rev A 08 19

70934 420 30 Master Bottle Label Approval Rev A 08 19
Topiramate Tablets USP 100 mg bottle label showing 30 tablets, marked Rx Only. The label displays storage instructions to keep at 20° to 25°C controlled room temperature, keep out of reach of children, and protect from moisture. Labeler is Denton Pharma, Inc. dba Northwind Pharmaceuticals. Front and side label views are shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.